BACKGROUND: Genetic factors play important roles in lung cancer susceptibility. In this study, we replicated the association of 5p15.33 and 6p21.33 with familial lung cancer. Taking into account the previously identified genetic susceptibility variants on 6q23-25/RGS17 and 15q24-25.1, we further determined the cumulative association of these four genetic regions and the population attributable risk percent of familial lung cancer they account for. METHODS: One hundred ninety-four case patients and 219 cancer-free control subjects from the Genetic Epidemiology of Lung Cancer Consortium were used for the association analysis. Each familial case was chosen from one high-risk lung cancer family that has three or more affected members. Single nucleotide polymorphisms (SNP) on chromosomal regions 5p15.33, 6p21.33, 6q23-25/RGS17, and 15q24-25.1 were assessed for their associations with familial lung cancer. The cumulative association of the four chromosomal regions with familial lung cancer was evaluated with the use of a linear logistic model. Population attributable risk percent was calculated for each SNP using risk ratio. RESULTS: SNP rs31489 showed the strongest evidence of familial lung cancer association on 5p15.33 (P = 2 x 10(-4); odds ratio, 0.57; 95% confidence interval, 0.42-0.77), whereas rs3117582 showed a weak association on 6p21.33 (P = 0.09; odds ratio, 1.47; 95% confidence interval, 0.94-2.31). Analysis of a combination of SNPs from the four regions provided a stronger cumulative association with familial lung cancer (P = 6.70 x 10(-6)) than any individual SNPs. The risk of lung cancer was increased to 3- to 11-fold among those subjects who had at least one copy of risk allele at each region compared with subjects without any of the risk factors. These four genetic regions contribute to a total of 34.6% of familial lung cancer in smokers. CONCLUSIONS: The SNPs in four chromosomal regions have a cumulative and significant association with familial lung cancer and account for about one-third of the population attributable risk for familial lung cancer.
BACKGROUND: Genetic factors play important roles in lung cancer susceptibility. In this study, we replicated the association of 5p15.33 and 6p21.33 with familial lung cancer. Taking into account the previously identified genetic susceptibility variants on 6q23-25/RGS17 and 15q24-25.1, we further determined the cumulative association of these four genetic regions and the population attributable risk percent of familial lung cancer they account for. METHODS: One hundred ninety-four case patients and 219 cancer-free control subjects from the Genetic Epidemiology of Lung Cancer Consortium were used for the association analysis. Each familial case was chosen from one high-risk lung cancer family that has three or more affected members. Single nucleotide polymorphisms (SNP) on chromosomal regions 5p15.33, 6p21.33, 6q23-25/RGS17, and 15q24-25.1 were assessed for their associations with familial lung cancer. The cumulative association of the four chromosomal regions with familial lung cancer was evaluated with the use of a linear logistic model. Population attributable risk percent was calculated for each SNP using risk ratio. RESULTS: SNP rs31489 showed the strongest evidence of familial lung cancer association on 5p15.33 (P = 2 x 10(-4); odds ratio, 0.57; 95% confidence interval, 0.42-0.77), whereas rs3117582 showed a weak association on 6p21.33 (P = 0.09; odds ratio, 1.47; 95% confidence interval, 0.94-2.31). Analysis of a combination of SNPs from the four regions provided a stronger cumulative association with familial lung cancer (P = 6.70 x 10(-6)) than any individual SNPs. The risk of lung cancer was increased to 3- to 11-fold among those subjects who had at least one copy of risk allele at each region compared with subjects without any of the risk factors. These four genetic regions contribute to a total of 34.6% of familial lung cancer in smokers. CONCLUSIONS: The SNPs in four chromosomal regions have a cumulative and significant association with familial lung cancer and account for about one-third of the population attributable risk for familial lung cancer.
Authors: Kavita Y Sarin; Peggie Cheung; Daniel Gilison; Eunice Lee; Ruth I Tennen; Estee Wang; Maja K Artandi; Anthony E Oro; Steven E Artandi Journal: Nature Date: 2005-08-18 Impact factor: 49.962
Authors: Toru Sasaki; Eugene C Gan; Andrew Wakeham; Sally Kornbluth; Tak W Mak; Hitoshi Okada Journal: Genes Dev Date: 2007-04-01 Impact factor: 11.361
Authors: O Johannsson; E A Ostermeyer; S Håkansson; L S Friedman; U Johansson; G Sellberg; K Brøndum-Nielsen; V Sele; H Olsson; M C King; A Borg Journal: Am J Hum Genet Date: 1996-03 Impact factor: 11.025
Authors: Jinkuk Choi; Lucinda K Southworth; Kavita Y Sarin; Andrew S Venteicher; Wenxiu Ma; Woody Chang; Peggie Cheung; Sohee Jun; Maja K Artandi; Naman Shah; Stuart K Kim; Steven E Artandi Journal: PLoS Genet Date: 2007-12-13 Impact factor: 5.917
Authors: T Wang; T Chen; A Thakur; Y Liang; L Gao; S Zhang; Y Tian; T Jin; J J Liu; M Chen Journal: Clin Transl Oncol Date: 2015-03-06 Impact factor: 3.405
Authors: Shelley B Hooks; Phillip Callihan; Molly K Altman; Jillian H Hurst; Mourad W Ali; Mandi M Murph Journal: Mol Cancer Date: 2010-11-02 Impact factor: 27.401
Authors: László G Puskás; Imola Mán; Gabor Szebeni; László Tiszlavicz; Susan Tsai; Michael A James Journal: Mol Cancer Ther Date: 2016-03-03 Impact factor: 6.261